FDG PET/CT in Lung Cancer Staging
NCT02738398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-02-27
Summary
Prospective study of the effects of image acquisition and reconstruction parameters on accuracy of FDG PET/CT mediastinal nodal staging in NSCLC
Conditions
- Non-Small Cell Lung Cancer (NSCLC)
Interventions
- RADIATION
-
FDG PET/CT
Sponsors & Collaborators
-
Abramson Cancer Center at Penn Medicine
lead OTHER
Principal Investigators
-
Daniel Pryma, MD · Abramson Cancer Center at Penn Medicine
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2026-01-27
- Completion
- 2026-01-27
Countries
- United States
Study Locations
More Related Trials
-
Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer
NCT00083083 ·Status: UNKNOWN ·Phase: PHASE2
-
68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients
NCT05543954 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
PET/MR Imaging in Lung Cancer
NCT03739281 ·Status: TERMINATED ·Phase: NA
-
18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study
NCT02938546 ·Status: UNKNOWN ·Phase: PHASE3
-
Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET
NCT00180154 ·Status: COMPLETED
-
Added Value of PET/CT in Lung Cancer
NCT06494800 ·Status: NOT_YET_RECRUITING
-
Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer
NCT02664792 ·Status: COMPLETED ·Phase: NA
-
The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules
NCT00598065 ·Status: COMPLETED ·Phase: NA
-
MRI Optimization Study in Stage III NSCLC
NCT02076282 ·Status: UNKNOWN
-
Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images
NCT01109953 ·Status: TERMINATED
-
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
NCT04726215 ·Status: UNKNOWN ·Phase: PHASE2
-
Influence of PET/CT Radiomic Features on the Outcome of Lung Cancer Patients
NCT03648151 ·Status: COMPLETED
-
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
NCT06107374 ·Status: RECRUITING ·Phase: PHASE2
-
Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung Cancer
NCT01507428 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging NSCLC Treatment Response to Immunotherapy
NCT02753569 ·Status: COMPLETED
-
Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.
NCT06168877 ·Status: COMPLETED
-
FDG-PET/CT Imaging as Early Predictor of DP
NCT02476734 ·Status: COMPLETED
-
The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients
NCT06082492 ·Status: RECRUITING ·Phase: NA
-
PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery
NCT00002930 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
NCT04678440 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
To Evaluate the Impact of PET/CT on Radiation Treatment Planning in Relation to Changes in GTV in Stage 3 NSCLC
NCT01888692 ·Status: TERMINATED
-
Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
NCT00865319 ·Status: COMPLETED ·Phase: PHASE2
-
Positron Emission Tomography Scan and CT Scan in Planning Radiation Therapy for Patients With Stage II or Stage III Non-Small Cell Lung Cancer
NCT00310219 ·Status: COMPLETED ·Phase: NA